Global Rapid Diagnostic Leader SD. Company Introduction.
-
Upload
kimberly-taylor -
Category
Documents
-
view
225 -
download
0
Transcript of Global Rapid Diagnostic Leader SD. Company Introduction.
Global Rapid Diagnostic Leader SD
Company Introduction
Product Line
Products List
Hepatitis B, C HBsAg, Anti-HBs, HCV HBeAg/
HBsAg Infectious Disease
HIV-1/2, Syphilis, TB, Malaria,
H.pylori, Chlamydia Ag, Dengu
e IgG/IgM, Leprosy, Salmonell
a typhi, Rotavirus, Tetanus, Infl
uenza/H5, RSV, Rubella IgG/Ig
M Tumor Marker
AFP, CEA, PSA, CEA/AFP, F
OB Drug of Abuse
MOP, MET, AMP, COC, THC,
MET/THC, MDMA (ecstasy) Fertility Hormone
hCG, LH, FSH Veterinary Tests
Heartworm, Distemper, Parvo
virus, FMD
Rapid Tests
• Urocolor (1~11para) Urometer 600
Urine Strip & reader
New Products Development
Expanding Into NEWbusiness fields
Present(In 2006)
New Rapid Test
• New Patent Device Fromat• Rubella IgG/IgM, Torch, Rota/Adeno, • Strep A, S. pnemoniae
DNA Chip
• Infectious Disease DNA Chip
• Congenital Disease DNA Chip
• Tumor DNA Chip
Long term (In 2008~ )
Short term(In 2006~2007)
• Concept of Lab on a Chip• Infectious Disease Panel : HIV1/2, Syphilis, HBV, TB, Malaria, HCV• Tumor Markers Panel : AFP, CEA, PSA, CA19, CA125, CA15• Allergy Panel: Food Allergy, Pollen Allergy
Protein Chip
Blood Glucose Meter
Competitiveness of Technology
Market leader World-first developed products
HIV ½ antibody One Step Test (three lines) 2001
SARS Anti-Coronavirus Test 2003
AIV Ag Test (including H5) for veterinary use 2004
Influenza H5 Rapid test for human use 2005
HIV1/2
1 2 C
Int’l Quality Approval
Item WHO Evaluation CE Mark USA FDA
HIV1/2 Completed Under process -
HCV Completed - -
Syphilis Completed Completed -
HBsAg Completed - -
Malaria - Completed -
hCG - Completed Completed
H.pylori - Completed -
Dengue - Completed -
Influenza - Completed
Rota - Completed -
Urine - Completed Under process
TB Under process - -
““Products Evaluation, Registration and Approval ”
Sales Network
“ 125 distributors in 75 Countries ”
“ 12 Domestic distributors”
Asia 18 countries
China, Japan, TaiwanThailand, India, Nepal Vietnam, the Philippines Bangladesh, Sri LankaMyanmar, PakistanIndonesia, MalaysiaHong Kong, MongolAustralia.Singapore, …
Middle East 12 countries
Iran, Syria, YemenJordan, Israel, Lebanon. PalestineSaudi Arabia,QatarEgypt. U.A.E.Oman,
Europe 17 countries
Germany, Swiss, ItalyRomania, Poland, Turkey, Finland, UK, Lithuania, Russia, Croatia, France, Bulgaria,Denmark,Netherlands
America/ Africa28 countries
USA, Canada ,Mexico, ,Panama, Bahamas,Guyana Brazil, Colombia, GuatemalaPeru, Venezuela,Paraguay, Honduras,Ecuador…..Cameron, Sudan, NigeriaMozambique, South AfricaUganda, Kenya, TanzaniaGhana, Benin, Burkina FasoMalawi, Zimbabwe…
Sales Network in Overseas Markets
Domestic market
12 Distributors by Region
Domestic Sales Network
SuWon
Seoul
DaeJeon DaeGu
Busan
GwangJu
JeunJu
WonJu
ChungJu
KangNung
Changwon
Jeju
Influenza virus
General
History
Diagnostic Tools
AIV _ Human Infection
Structure of Influenza virus
HA Antigen : Help virus absorption into cells NA Antigen : help virus segregation from cells
Influenza Virus
Acute respiratory illness caused by Influenza viruses A subtype or B subtype
(Karl G Nicholson, et al Lancet 2003; 362: 1733-45)
•Major : A (H, N)
•Human Infection•H1N1
•H3N2
•H2N2
•H5N1
N9
H10
H11
H12
H13
H14
H15
N1
N2
N3
N4
N5
N6
N7
N8
H1
H2
H3
H4
H5
H6
H7
H8
H9
Influenza Outbreak in 20th centuries
H1N1 H1N1
H2N2
H3N2
1918: “Spanish Flu” 1957: “Asian Flu” 1968: “Hong Kong Flu”
2003~4: “AIV H5”
H5N1
Major Influenza Pandemics Period
“Spanish Flu” Pandemic (1918-1919)
World-wide population 2 bil.
(100 %)
Infected polulation 0.4 bil. (20 %)
Deaths 20-40 mil. (1-2 %)
*Outbreak in healthy young people, in the majority of cases
Killed an estimated more than 1 mil.
*Outbreak in old people, or patients with chronic disease, in the majority of cases
‘Asian / HongKong Flu’ Pandemic (1957, 1968)
Outbreak of HongKong A/H5N1 (1997)
• Infection – 18
• Death- 6
• Protective slaughter on 1.
5 mil. Chicken
• No infection between hu
man
Outbreak of Vietnam A/H5N1 (2003~5)
• Infection – 93
• Death- 42
• 1999 ; HongKong, GhuangDong _ A/H9N2 – HongKong ; 2 persons infection – GhuangDong 5 persons infection
• 2003 ; HongKong _ A/H5N1 – 2 persons (family) infection, 2 persons death– Travel experience to Fujian
• 2003 ; Netherland _ A/H7N7– Infection from human to human
• 2003 : HongKong _ A/H9N2– 1 person infection
The Latest New Subtype Infection
Number of cases / Influenza H5/N1Number of cases / Influenza H5/N1
•
AIV_ human Infection Mechanism (1)
Migratory birds
poultry
poultry
AIV_ human Infection Mechanism (2)
Migratory birds
poultry
AIV_ human Infection Mechanism (3)
Migratory birds
Influenza Diagnostic Table
Procedure Influenza Types Detected
Acceptable Specimens
Time for Results
Rapid result available
Viral culture
A and B NP swab , throat swab, nasal wash, bronchial wash, nasal aspirate, sputum
5-10days
No
Immunofluorescence DFA Antibody Staining
A and B NP swab, nasal wash, bronchial wash, nasal aspirate, sputum
2-4 hours No
RT-PCR A and B NP swab , throat swab, nasal wash, bronchial wash, nasal aspirate, sputum
1-2 days No
Serology A and B paired acute and convalescent serum samples
>2 weeks No
Enzyme Immuno Assay(EIA)
A and B NP swab , throat swab, nasal wash, bronchial wash
2 hours No
RapidDiagnostic Tests
Poultry AIV – human infection Surveillance of Epidemiology case study by Korea CDC
<Step 1>
• Surveillance on Central Hospital around region of
outbreak of AIV
– Review & Collection of hospitalized records
– Collection of blood or respiratory specimen from
possible case or not-caused ARDS
– Laboratory diagnosis at CDC, Dept. Of infectious
disease control
<Step 2>
• If, detection of AIV_human infection possible case,
you should work on enlarged surveillance with all
general hospital adjacent to the region of outbreak
of AIV.
Poultry AIV – human infection Surveillance of Epidemiology case study by Korea CDC
• Virus isolation in tissue culture cells, or virus inoculation into egg
• Viral nucleic acid : RT-PCR• Hemagglutination Inhibition test (HI)• Neutralization (NT)
– Infectious virus
• ELISA:– recombinant antigen
• Western blot– recombinant antigen
Diagnosis of AIV infectionto Human
Description Specimen Collection time
Virus isolation
Respiratory specimen
Early stage of onsetNucleic acid
RAT (rapid antigen test)
Serological Serumacute : Early stage of onsetcovalescent : after 3 weeks
Sample collection
Diagnosis of AIV infectionto Human
Specimen collection
Respiratory specimen Serum
HI
NTRT-PCR /
Virus culture
Participates in WHO/CDC programs for flu surveillance
First, by Rapid Antigen Testing
Diagnosis Flow chart
Diagnostic criteria (WHO, Vietnam 2004. 1.24)
• Possible Case– Acute Respiratory Disease Syndrome,
– 38℃ high fever (and) cough (and/or) nasopharyngeal pain, Contact with A(H5N1) confirmed case during infection, or Visit at AIV outbreak poultry farm within 1 week before onset, or Person working at laboratory on research with AIV specimen
Diagnosis of AIV infectionto Human
• Probable Case– Laboratory diagnostic test results on AIV human infection _ Positi
ve (FA +H5 mcAb analysis)
– Or, no cause of other respiratory disease onset
• Confirmed Case– A(H5N1) virus isolation
– H5 _ PCR positive
– H5 _ specific antibody titer x 4 in paired acute and convalescent serum samples
Diagnostic criteria (WHO, Vietnam 2004. 1.24)
Diagnosis of AIV infectionto Human
SD BIOLINE Influenza Antigen (type A & B)SD BIOLINE Influenza H5 (A/H5N1)
RAT (Rapid Antigen Test)
SD BIOLINE Influenza Antigen Kit
SD BIOLINE Influenza Antigen rapid test is a chromatographic immunoassay for the differential and qualitative detection of influenza virus type A and type B antigens directly from nasal swab specimens, throat swab specimens,nasal/nasopharyngealaspirate specimens.
- Detection by Direct Sandwich System
C line B line(Influenza B type) A line(Influenza A type)
Flu B Ag
Gold
-Target materials : Influenza antigen (type Aband B) in respiratory specimen
mouse monoclonal anti-influenza B
mouse monoclonal anti-influenza A/B-gold conjugate
Gold
Gold
in specimen in specimenFlu A Ag
mouse monoclonal anti-influenza A
Test Principle & Major active ingredient
Test Results AppearanceNegative Influenza type A Influenza type B
positive positive
Test procedure & Interpretation
① Transfer assay diluent into test tube (approximately 300uL).
② Insert the patient swab sample into the test tube and mix well.
③ Place the Test Strip into the test tube.
④ Read result at 10 ~ 15 minutes.
Sample collection & Test procedure
1. Nasal swab
2. Diluent 300 uL
SD BIOLINE Influenza Antigen Kit
Sample collection & Test procedure
3. Extraction
4. Discard the swab.
SD BIOLINE Influenza Antigen Kit
Sample collection & Test procedure
5. Insert test strip into tube.
6. Migration
Interpretation of Test Results
A/H1N1 A/H3N2 B
3+ 2+ 1+ 3+ 2+ 1+ 3+ 2+ 1+ Neg.
Comparison Table (Influenza RAT)
Q SD BD
Virus types (strains) Detection Sensitivity
Influenza virus,TypeA(H1N1) HN2242 (cultured sample) ○ 0.5HAU
Influenza virus,TypeA(H1N1) HN2253 (cultured sample) ○ 0.25HAU
Influenza virus,TypeA(H1N1) HN2475 (cultured sample) ○ 0.125HAU
Influenza virus, TypeA(H1N1)Taiwan/1/86 81N73 ○ 0.5HAU
Influenza virus, TypeA(H1N1)Beijing/262/95 81N73-2 ○ 0.5HAU
Influenza virus, TypeA(H1N1)/WS/33 VR1520(27HAU) (cultured sample) ○ 0.5HAU
Influenza virus,TypeA(H3N2) HN30109 (cultured sample) ○ 0.125HAU
Influenza virus,TypeA(H3N2) HN30135 (cultured sample) ○ 0.0625HAU
Influenza virus,TypeA(H3N2) HN30240 (cultured sample) ○ 0.25HAU
Influenza virus, TypeA(H3N2)/Hongkong/8/68 VR544(26HAU) (cultured sample) ○ 0.5HAU
Influenza virus, TypeA(H3N2)/Shangdong/9/93 81N74 ○ 0.25HAU
Influenza virus, TypeA(H3N2)/Panama/2007/99 81N74-1 ○ 0.125HAU
Influenza virus, TypeA(H3N2)Kiev/301/94 like/Johannesburg/33/94 81N74-2 ○ 0.125HAU
Sensitivity per the virus type of strains
Virus types (strains) Detection Sensitivity
Influenza virus, TypeA(H5N1)(cultured sample 210HAU) ○ 0.2HAU
Influenza virus, TypeA(H5N2)(cultured sample 25HAU) ○0.05HAU
Influenza virus, TypeA(H5N3)/HK/80(26~7HAU) ○ 0.05HAU
Influenza virus,TypeA(H7N1)/Duck/Hongkong/301/78 (26HAU) ○ 0.1HAU
Influenza virus,TypeA(H9N2)/TK/WS/1/66 ○ 0.5HAU
Influenza virus,TypeA(H2N2) /SINGAPORE/1/57 ○ 0.25HAU
Influenza virus,TypeA(H13N6)/GULL/MALAND ○ 0.125HAU
Influenza virus,TypeA(H12N5)/DUCK/ALBERTO/60/76 ○ 0.05HAU
Influenza virus,TypeA(H8N4) /TK/OT/6/18/68 ○ 0.25HAU
Influenza virus,TypeA(H11N9)/DUCK/MEMPHIS/546/74 ○ 0.125HAU
Influenza virus,TypeA(H6N5) /SHEARWATER/AUSTRALIER/1/72 ○ 0.0625HAU
Influenza virus,TypeA(H10N7)/CHICKEN/GR/N/49 ○ 0.5HAU
Influenza virus,TypeA(H4N6) /CZECH0/56 ○ 0.25HAU
Influenza virus,TypeA(H3N6) /DUCK/UKRINE/1/63 ○ 0.125HAU
Influenza virus,TypeB ○ 0.1HAU
Sensitivity per the virus type of strains
Detection Limit of each virus type
Influenza Virus (strain)
Quidel BD SD Remark
Type A, H1N1(2475) 1/320 1/640 1/640Better than Quidel Equal to BD
Type A, H3N2(30135) 1/640 1/1280 1/1280Better than QuidelEqual to BD
Type A, H5N1 1/160 1/320 1/5120 Better than Quidel, BD
Type A, H5N2 1/10 1/10 1/640 Better than Quidel, BD
Type A, H5N3 1/1280 1/1280 1/1280 Equal to Quidel, BD
Type A, H7N1 1/640 1/1280 1/640Equal to Quidel (has thick band)Less than BD
Type A, H9N2 1/10240 1/20480 1/10240Equal to QuidelLess than BD
Type B 1/2560 1/2560 1/2560 Equal to Quidel, BD
Comparison data vs. RAT competitor
Clinical Evaluation Studies
The performance of the SD BIOLINE Influenza antigen test was compared to cell culture or RT-PCR methods in a multi-center field clinical study. In this multi-center, a combination of nasal swabs and throat swabs specimens were collected from total 341 patients.
*Test Period ; Oct.2003 ~ May 2005
*Test Region ; Korea & Overseas Vietnam (H5) HongKong Thailand, etc
Summary of Clinical Evaluation Data
Clinical Evaluation Studies
Clinical evaluation studies results performed at National Institute of Hygiene and Epidemiology, Vietnam (including H5 Huma
n cases)*Test period : Dec.2004 ~ Dec.2005
Competitiveness of SD BIOLINE Influenza Antigen test
Why should you use “SD BIOLINE Influenza Antigen Rapid Test”?
SD kit can cover all influenza virus type.
SD kit can detect AIV infection in Human (A/H5N1).
SD kit can differentiate influenza virus type A and B
SD kit is very useful as POCT (point of care testing), on-site test.
SD BIOLINE Influenza H5 kit
SD BIOLINE Influenza H5 rapid test is a chromatographic immunoassay for the qualitative detection of hemagglutinin H5 antigen of avian influenza (AI)virus directly from nasal swab/aspirate specimens, throat swab specimens,tracheal aspiratespecimens onAI virus human infectioncases.
- Detection by Direct Sandwich System
C line T line (Influenza A/H5)
-Target materials : Hemagglutinin H5 antigen of avian influenza (AI) virus in respiratory specimen
mouse monoclonal anti-influenza H5-gold conjugate
Gold
Gold
in specimenFlu H5 Ag
mouse monoclonal anti-influenza H5
Test Principle & Major active ingredient
specimen collection & preparation
① Nasal swab
② Nasal aspirate
③ Throat swab
④ Tracheal aspirate (Especially, test results with the tracheal
aspirate specimens would be recommendable, because the
majority of AIV may exist at the tracheal position.)
specimen collection & preparation
If the specimen should be tested later, swab specimens should be placed into 1 ~ 2 ml of transport media or saline by direct extraction.
Transport media : Use of the following transport media has been tested and found to be compatible with SD BIOLINE Influenza Antigen test.
Saline EMEM+1%BSAPBS EMEM+0.5%BSAPBS+0.5%BSA Trypticase soy Broth+0.5%BSAPBS+0.5%Gelatin Trypticase soy Broth+0.5% gelatin
Special Precautions on Specimen collection & preparation
① Use of fresh sample is very important for getting
accurate results.
② The specimen which have ever been thawed after
freezing may results in decreased test sensitivity
from the deterioration or modification of H5 antigen.
So, repeated freezing and thawing of specimen must
not be used for this test.
③ Finally, to get accurate results, specimen should be
tested as soon as possible after collection.
Test procedure & Interpretation; nasal swab, throat swab
① Transfer assay diluent into test tube (approximately 300uL).
② Insert the patient swab sample into the test tube and mix well.
③ Place the Test Strip into the test tube.
④ Read result at 10 ~ 15 minutes.
Test procedure & Interpretation; nasal aspirate, tracheal aspirate
① Pipet 100uL of assay diluent and 100uL of aspirate specimen int
o test tube. And mix well.
② Place the Test Strip into the test tube.
③ Read result at 10 ~ 15 minutes.
Test Results Appearance
; Influenza A/H5 positive
SD BIOLINE Influenza H5 Limit of Detection : H5N1
With H5N1 (ES/03) : virus titer 27 HA unit MDL(*)
32HAU 16HAU 8HAU 4HAU 2HAU 1HAU
+++ +++ ++ ++ + +
(*)minimum detectable level
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen
• Case 1 :
At the WHO Collaborating Centre for Reference and Research on Influenza
Dr. Aeron Hurt
Address : 45 Poplar Rd,Parkville, Victoria 3052, Australia
SD H5 kit could detect as below;
A/Chicken/Vietnam #8 (-irradiated) – A(H5N1) – Egg grownA/Duck/Vietnam #7A (-irradiated) – A(H5N1) – Egg grownA/?/Vietnam #Pooled (-irradiated) – A(H5N1) – Egg grown
•Case 2 :
At the Avian Section, Diagnostic Virology Laboratory National Veterinary Services Laboratories, APHIS, USDA Dr. Janice C. Pedersen, Microbiologist SD H5 kit could detect as below;
TY/MN H5N2 10-1
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen
• Case 3 :
At the ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA
LOMBARDIA E DELL’EMILIA ROMAGNA “BRUNO UBERTINI”
(ENTE SANITARIO DI DIRITTO PUBBLICO)
Address : Via Bianchi, 9, 25124 BRESCIA, ITALY
SD H5 kit could detect as below;
A/ty/It/90302/05/H5N2 (LPAI) - 104,5EID50/ml as detection limit.
•Case 4 : At the OIE AIV Reference Laboratory Clinic for bird, reptile, amphibia and fishes Universita"t Giessen, Germany
Justus-Liebig-University Giessen Frankfurter, Germany
Performed by Prof. Dr. E. F. Kaleta,
SD H5 kit could detect as below;
H5Nx: Cell culture supernatant fluids containing H5 virus (H5N2, H5N9, H5N1)
were cpe pos. in chick embryo cell cultures up to 10 to minus three.
Applications of Influenza Rapid kits on Avian Influenza diagnosis programs
Negative
Respiratory specimen
RAT by SD BIOLINE Influenza Ag test
In case of emergency that happen to outbreak of AI in the
poultry, SD BIOLINE Influenza H5 test should be used directly.
Type A positive Type B positive
RAT by SD BIOLINE Influenza H5 test
Treatment or Confirm test by RT-PCR/viral culture
H5 positive negative
Treatment or Confirm test by RT-PCR/viral culture
Send Samples to Reference Laboratory that participates in WHO/CDC programs for flu/H5 surveill
ance, immediately
**WHO recommendations on the use of rapid testing for influenza diagnosis ;
- Influenza surveillance should be used to guide the optimal use of RAT (rapid antigen test).
- At the beginning of the influenza season or an influenza outbreak, RAT may influence on clinical decisions and contribute to clinical awareness.
• For the screening test, the Sole H5 Avian Influenza Antigen Rapid Kit in the world
• Accurate detection on H5N1 samples isolated from Human infection cases, with High Sensitivity and Specificity
• With same kits, we’ve got lots of AI positive cases through HPAI (H5N1~H5N9) detection in the farm, market, or laboratory by use of feces or cloacal swab as veterinary use.
• Easy assay procedure: No technical expert and No equipment is required
• Labor & Time saving because of fast results
SD BIOLINE Influenza H5 Advantages as an aid of H5 diagnosis
Global Rapid Diagnostic Leader SD
THANK YOU